Cell-based therapeutics
Q Therapeutics
615 Arapeen Drive, Suite 102
Salt Lake City
UT
84108
801-582-5400
Deal Flow
Fundings
| Closing Date | Round | Amount |
|---|---|---|
| 02/08/2008 | Unattributed | $8,119,000 |
| 02/01/2008 | Series B | $15,000,000 |
| 07/01/2005 | Series A | $4,500,000 |
Mergers & Acquisitions
Public Offerings
Company Snapshot
Yes
Biotechnology | Therapeutics
Active
Not Assigned
$1,000,000
$27,619,000
20
20
Key People
-
Vicki Farrar
VP of Regulatory Affairs and Intellectual Property
-
Deborah Eppstein
CEO and President
-
Mahendra Rao
Scientific Co-founder and Chief Scientific Consultant
-
Steven J. Borst
VP of Finance and Corporate Development






